Newsletter Archives

Showing 221 to 240 of 702 articles.

EBM Focus - Volume 15, Issue 1

Putting morning meds for hypertension to bed – nighttime dosing seems better

EBM Focus - Volume 14, Issue 25

2019 Year in Review

EBM Focus - Volume 14, Issue 24

Statin’ young: Starting statins in childhood appears to reduce cardiovascular mortality for those with familial hypercholesterolemia

EBM Focus - Volume 14, Issue 23

“Confirmatory trial” creates uncertainty about benefit of 17 alpha-hydroxyprogesterone for prevention of premature birth

EBM Focus - Volume 14, Issue 22

Holy Cow! Reheating the debate on eating red meat

EBM Focus - Volume 14, Issue 21

A proctoscopy of the new colorectal cancer screening guideline

EBM Focus - Volume 14, Issue 20

PREDICTing the net benefit of aspirin for primary prevention

EBM Focus - Volume 14, Issue 19

Oral semaglutide: May be safe for those at high cardiovascular risk

EBM Focus - Volume 14, Issue 18

CRP-guided antibiotic therapy for acute exacerbations of COPD: fewer prescriptions, similar outcomes

EBM Focus - Volume 14, Issue 17

Remain J-aded: LDL-C levels below 70 mg/dL associated with increased risk of intracranial hemorrhage

EBM Focus - Volume 14, Issue 16

Don’t overDAPT it: 1 month may be enough after everolimus-eluting stent for low-risk patients

EBM Focus - Volume 14, Issue 15

Antenatal cannabis use may increase risk of preterm delivery

EBM Focus - Volume 14, Issue 14

Aflibercept for diabetic macular edema with preserved visual acuity: Seeing dollar signs

EBM Focus - Volume 14, Issue 13

Thiazides and skin cancer? Don’t get burned by the hype.

EBM Focus - Volume 14, Issue 12

Once again, MMR vaccination does not increase risk of autism, even among high-risk children

EBM Focus - Volume 14, Issue 11

Pushing the needle: tPA for wake up strokes, or beyond 4.5 hours after ischemic stroke symptom onset, may improve function at 90 days

EBM Focus - Volume 14, Issue 10

Expert opinion and low-quality evidence still drive many strong recommendations in cardiology

EBM Focus - Volume 14, Issue 9

Canagliflozin for renal protection: Not the next ACE inhibitor

EBM Focus - Volume 14, Issue 8

Forty to fifty shades of grey: ACP guidance statement highlights the harms of screening mammography among average-risk women aged 40-49

EBM Focus - Volume 14, Issue 7

Hold the knife: TAVR reduces the composite of death, stroke, and rehospitalization compared to open surgery even among low-risk patients with severe symptomatic AS